1. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
   Loredana Salerno et al, 2017, European Journal of Medicinal Chemistry CrossRef
2. Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1
   Bingqing Cheng et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Clinical Significance of Heme Oxygenase 1 in Tumor Progression
   Mariapaola Nitti et al, 2021, Antioxidants CrossRef
4. Histone deacetylase inhibitor LMK-235-mediated HO-1 expression induces apoptosis in multiple myeloma cells via the JNK/AP-1 signaling pathway
   Xinyao Li et al, 2019, Life Sciences CrossRef
5. The prognostic and therapeutic potential of HO-1 in leukemia and MDS
   Mohammad Sadeghi et al, 2023, Cell Communication and Signaling CrossRef
6. Heme oxygenase-1 protects bone marrow mesenchymal stem cells from iron overload through decreasing reactive oxygen species and promoting IL-10 generation
   Zheng Y. Yu et al, 2018, Experimental Cell Research CrossRef
7. PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia
   Yong June Choi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. Association of long non-coding RNAs and ABO blood groups with acute lymphoblastic leukemia in Egyptian children
   Noha H. Sayed et al, 2024, Non-coding RNA Research CrossRef
9. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
   Corinna Spohr et al, 2022, Leukemia CrossRef
10. Up-regulation of HO-1 promotes resistance of B-cell acute lymphocytic leukemia cells to HDAC4/5 inhibitor LMK-235 via the Smad7 pathway
    Yongling Guo et al, 2018, Life Sciences CrossRef
11. GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
    Lois M. Mulligan, 2019, Frontiers in Physiology CrossRef
12. Heme Oxygenase-1 Has an Antitumor Role in Breast Cancer
    Norberto Ariel Gandini et al, 2019, Antioxidants & Redox Signaling CrossRef